L-dopa-Dependent Effects of GLP-1R Agonists on the Survival of Dopaminergic Cells Transplanted into a Rat Model of Parkinson Disease
Cell therapy is a promising treatment for Parkinson’s disease (PD), however clinical trials to date have shown relatively low survival and significant patient-to-patient variability. Glucagon Like Peptide-1 receptor (GLP-1R) agonists have potential neuroprotective effects on endogenous dopaminergic...
Saved in:
Main Authors: | Osama F. Elabi, Jeffrey S. Davies, Emma L. Lane |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7737bd875e064af7a8c6239e9244d68f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Terapia neuroprotectora de la Enfermedad de Parkinson
by: Miranda,Marcelo, et al.
Published: (2004) -
Emerging role of GLP-1 receptor agonists in the treatment of obesity
by: Neff LM
Published: (2010) -
Long-term changes in short-interval intracortical facilitation modulate motor cortex plasticity and L-dopa-induced dyskinesia in Parkinson's disease
by: Andrea Guerra, et al.
Published: (2022) -
LC-MS/MS METHOD FOR L-DOPA QUANTIFICATION IN DIFFERENT TISSUES OF VICIA FABA
by: Pavón-Pérez,Jessy, et al.
Published: (2019) -
PROTONATION EQUILIBRIA OF L-DOPA AND 1,10 PHENONTHROLINE IN PROPYLENE GLYCOL-WATER MIXTURES
by: RAMA RAJU,B, et al.
Published: (2011)